Rani Therapeutics Holdings Class ARANI
13F holders, Q2 2025 (June 30)39holders +1
7new positions
6sold out
1famous investor
$0.51avg. 13F price*
At the end of Q2 2025, 39 institutions reported holding Rani Therapeutics Holdings Class A (RANI) in their 13F filings, up 1 from Q1 2025. 7 opened new positions and 6 sold out. The largest holders were Armistice Capital, LLC ($1.6M), Vanguard Group Inc. ($411K) and Nan Fung Group Holdings Ltd ($254K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Rani Therapeutics Holdings Class A
- CUSIP
- 753018100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $1.7M |
| Exits | 6 | $682K |
All 13F filers, Q1 2025 → Q2 2025: 3,455,248 shares bought and 605,973 shares sold, net +2,849,275 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 39 holders
| Armistice Capital, LLC | 0.06% | New | 3,151,354 | $1.6M |
| Vanguard Group Inc. | 0.00% | No change | 799,679 | $411K |
| Nan Fung Group Holdings Ltd | 0.40% | No change | 493,584 | $254K |
| United Services Automobile Association | 0.02% | No change | 302,743 | $156K |
| Takeda Pharmaceutical Co. Ltd. | 0.53% | No change | 203,190 | $104K |
| Geode Capital Management, LLC | 0.00% | Reduce -2.9% | 190,557 | $98K |
| Kestra Private Wealth Services, LLC | 0.00% | Add +12.2% | 156,140 | $80K |
| Citadel Advisors | 0.00% | New | 137,349 | $71K |
| BlackRock, Inc. | 0.00% | Add +86.6% | 118,652 | $61K |
| Northern Trust Corp. | 0.00% | Reduce -1.4% | 102,911 | $53K |
| CWA Asset Management Group, LLC | 0.00% | No change | 83,333 | $43K |
| Lasry Marc | 0.18% | No change | 62,887 | $32K |
| State Street Corp. | 0.00% | No change | 62,442 | $32K |
| UBS Group AG | 0.00% | Reduce -13.9% | 62,064 | $32K |
| King Luther Capital Management Corp. | 0.00% | No change | 58,000 | $30K |
| Janney Montgomery Scott LLC | 0.00% | Add +102.9% | 55,200 | $28K |
| Well Done, LLC | 0.01% | New | 52,014 | $27K |
| Motco | 0.00% | No change | 48,129 | $26K |
| Insigneo Advisory Services, LLC | 0.00% | No change | 47,500 | $24K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 46,500 | $24K |
| Brown Advisory Inc. | 0.00% | No change | 32,911 | $17K |
| Bank of America Corp. | 0.00% | Reduce -33.2% | 31,165 | $16K |
| Prime Capital Investment Advisors, LLC | 0.00% | No change | 27,208 | $14K |
| Gsa Capital Partners LLP | 0.00% | Reduce -43.1% | 25,391 | $13K |
| Lafayette Investments, Inc. | 0.00% | No change | 19,893 | $10K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | Reduce -24.7% | 15,396 | $8K |
| Choreo, LLC | 0.00% | No change | 11,813 | $6K |
| Cerity Partners LLC | 0.00% | No change | 10,000 | $5K |
| SBI Securities Co., Ltd. | 0.00% | Add +25.1% | 9,620 | $5K |
| Islay Capital Management, LLC | 0.00% | No change | 9,611 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 9,285 | $5K |
| Morgan Stanley | 0.00% | Reduce -51.9% | 7,020 | $4K |
| Osaic Holdings, Inc. | 0.00% | No change | 6,668 | $3K |
| Allworth Financial LP | 0.00% | No change | 3,119 | $2K |
| Raymond James Financial Inc. | 0.00% | New | 2,954 | $2K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 2,000 | $1K |
| Ameritas Advisory Services, LLC | 0.00% | New | 280 | $144 |
| JPMorgan Chase & Co. | 0.00% | No change | 71 | $36 |
| Royal Bank of Canada | 0.00% | New | 31 | $0 |
"% of holder's portfolio" is RANI's weight in each manager's 13F, not the share of Rani Therapeutics Holdings Class A the manager owns.